Katherine Payne

8.8k total citations · 1 hit paper
226 papers, 5.7k citations indexed

About

Katherine Payne is a scholar working on Economics and Econometrics, General Health Professions and Genetics. According to data from OpenAlex, Katherine Payne has authored 226 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Economics and Econometrics, 41 papers in General Health Professions and 35 papers in Genetics. Recurrent topics in Katherine Payne's work include Health Systems, Economic Evaluations, Quality of Life (93 papers), Economic and Environmental Valuation (25 papers) and Pharmacogenetics and Drug Metabolism (18 papers). Katherine Payne is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (93 papers), Economic and Environmental Valuation (25 papers) and Pharmacogenetics and Drug Metabolism (18 papers). Katherine Payne collaborates with scholars based in United Kingdom, United States and Australia. Katherine Payne's co-authors include Rachel Elliott, Linda Davies, Marion McAllister, Caroline Vass, Alexander Thompson, William G. Newman, Bruce Guthrie, Stewart W Mercer, Priscilla Alderson and Tamara Brown and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Nature Reviews Genetics.

In The Last Decade

Katherine Payne

216 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adapting clinical guidelines to take account of multimorbidity

2012 374 citations Bruce Guthrie, Katherine Payne et al. profile →

Peers

Countries citing papers authored by Katherine Payne

Since Specialization

Citations

This map shows the geographic impact of Katherine Payne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Payne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Payne more than expected).

Fields of papers citing papers by Katherine Payne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Payne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Payne. The network helps show where Katherine Payne may publish in the future.

Co-authorship network of co-authors of Katherine Payne

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Payne. A scholar is included among the top collaborators of Katherine Payne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Payne. Katherine Payne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Process Development for the First GMP Synthesis of SGD-9501-TFA, Part 2: Synthesis of the Payload, Linker, and Drug Linker 2024 ·Organic Process Research & Development ·Katherine Payne, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), A. T. Stair, (unknown), (unknown), (unknown), Aaron M. Whittaker	2
2	The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis 2024 ·SHILAP Revista de lepidopterología ·Bruce Guthrie, G Rogers, Shona Livingstone, Daniel R. Morales, Peter T. Donnan, Sarah Davis, (unknown), (unknown), Alexander Thompson, Katherine Payne	2
3	International Systematic Review of Utility Values Associated with Cardiovascular Disease and Reflections on Selecting Evidence for a UK Decision-Analytic Model 2024 ·Medical Decision Making ·(unknown), Alexander Thompson, Bruce Guthrie, Katherine Payne, G Rogers	1
4	Overcoming provider barriers to therapeutic drug monitoring of tumour necrosis factor inhibitors for rheumatoid arthritis: a qualitative analysis 2024 ·Rheumatology Advances in Practice ·Sean P. Gavan, Katherine Payne, Anne Barton	3
5	Risk stratification in breast screening workshop 2024 ·BMC Proceedings ·A. W. Anderson, Cristina Visintin, Antonis C. Antoniou, Nora Pashayan, Fiona J. Gilbert, Allan Hackshaw, (unknown), Harry Hill, Stuart Wright, Katherine Payne, G Rogers, Bethany Shinkins, Sian Taylor‐Phillips, Rosalind Given-Wilson	1
6	Capturing the Impact of Constraints on the Cost-Effectiveness of Cell and Gene Therapies: A Systematic Review 2023 ·PharmacoEconomics ·Sean P. Gavan, Stuart Wright, Fiona Thistlethwaite, Katherine Payne	4
7	Cost‐effectiveness of a policy‐based intervention to reduce melanoma and other skin cancers associated with indoor tanning* 2022 ·British Journal of Dermatology ·Martin Eden, (unknown), Louisa G. Gordon, Tracy Epton, Paul Lorigan, Lesley E. Rhodes, Richard Marais, Adèle C. Green, Katherine Payne	13
8	Predicting presenteeism using measures of health status 2021 ·Quality of Life Research ·(unknown), Katherine Payne, Alexander Thompson, Suzanne Verstappen	5
9	Sunbed Use among 11- to 17-Year-Olds and Estimated Number of Commercial Sunbeds in England with Implications for a ‘Buy-Back’ Scheme 2021 ·Children ·Louisa G. Gordon, (unknown), Martin Eden, Tracy Epton, Paul Lorigan, (unknown), Adèle C. Green, Katherine Payne	7
10	Higher donor body mass index is associated with increased hemolysis of red blood cells at 42‐days of storage: A retrospective analysis of routine quality control data 2020 ·Transfusion ·Rosemary L. Sparrow, Katherine Payne, Geoffrey G. Adams	11
11	Using qualitative methods for a conceptual analysis of measures of health status and presenteeism prior to a mapping study 2020 ·Quality of Life Research ·(unknown), Katherine Payne, Suzanne Verstappen	1
12	Generating evidence to inform health technology assessment of treatments for SLE: a systematic review of decision-analytic model-based economic evaluations 2020 ·Lupus Science & Medicine ·Sean P. Gavan, Ian N Bruce, Katherine Payne	6
13	A Systematic Review of Productivity in Economic Evaluations of Workplace Interventions: A Need for Reporting Criteria? 2019 ·Applied Health Economics and Health Policy ·(unknown), Suzanne Verstappen, Katherine Payne	7
14	Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study 2019 ·BMC Rheumatology ·Sean P. Gavan, Gavin Daker‐White, Katherine Payne, Anne Barton	3
15	Modeling the Economic Impact of Interventions for Older Populations with Multimorbidity: A Method of Linking Multiple Single-Disease Models 2019 ·Medical Decision Making ·(unknown), Matt Stevenson, Praveen Thokala, Katherine Payne, Maria Goddard	1
16	Can parents predict and accurately their child's behavior during a first dental restorative procedure? 2017 ·OhioLink ETD Center (Ohio Library and Information Network) ·Katherine Payne	0
17	The management of Otitis Media with Effusion (OME) in children with Cleft Palate: A feasibility study. (mOMEnt). 2015 ·Health Technology Assessment ·Ian N Bruce, Nicola Harman, Paula Williamson, Sean Tierney, Peter Callery, (unknown), Katherine Payne, Elisabeth Fenwick, Kevin O’Brien	1
18	The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation 2010 ·Health Technology Assessment ·Nigel Fleeman, C McLeod, A Bagust, Sophie Beale, Angela Boland, Y Dündar, A. Jørgensen, Katherine Payne, Munir Pirmohamed, Sudeep Pushpakom, T Walley, (unknown), Rumona Dickson	53
19	Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model 2006 ·Health Technology Assessment ·Linda Davies, Tamara Brown, Shana M Haynes, Katherine Payne, Rachel Elliott, Charles McCollum	166
20	Health Economics: Do or be done by 1996 ·Pharmaceutical journal/The pharmaceutical journal ·Rachel Elliott, Katherine Payne, Jonathan Silcock	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact